Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia

Overview of attention for article published in Journal of Blood Medicine, August 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

googleplus: 1 Google+ user

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

Dove Medical Press (NZ) Ltd, 03 Nov 2013

Abstract: Recent advances in our understanding of the molecular mechanisms underlying hypereosinophilia... Abstract: Recent…